Every material Form 8-K Vuzix Corp has filed with the SEC since May 15, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Vuzix reported second-quarter 2026 results for the three months ended June 30, 2026, in a press release dated August 13, 2026. Total sales fell 14% to $1.1 million from $1.3 million, while the net loss was $7.7 million, or $0.09 per share, compared with $0.10 per share a year earlier. The company had $17.3 million in cash and no debt at June 30, 2026, but operating cash use rose to $6.6 million from $4.8 million.
Total sales were $1.1 million versus $1.3 million, a 14% decline; product sales fell 15% to $0.9 million.
Net loss was $7.7 million, or $0.09 per share, compared with a loss of $7.7 million, or $0.10 per share, in the second quarter of 2025.
Research and development expense rose 20% to $3.1 million, while the gross loss narrowed to $0.6 million from $0.8 million.
Net cash used in operating activities was $6.6 million, up from $4.8 million; cash totaled $17.3 million with no current or long-term debt.
Vuzix entered an Open Market Sales Agreement with Jefferies LLC under which it may sell up to $100,000,000 of common stock from time to time at its discretion. The agreement replaces a prior Jefferies sales agreement from February 9, 2024, under which no sales will be made. Because new shares would be issued into the market, the program could dilute existing shareholders if the company uses it.
Agreement dated August 14, 2026 with Jefferies LLC as sales agent, covering up to $100,000,000 aggregate offering price
Jefferies commission is 3.0% of gross proceeds, plus reimbursement of certain expenses
Sales will be made under an effective Form S-3 (File No. 333-276997) and a prospectus supplement dated August 14, 2026
Replaces the prior Sales Agreement from February 9, 2024; no sales will be made under that prior agreement
Vuzix reported first-quarter 2026 results for the three months ended March 31, 2026, with total sales down 12% to $1.4 million as lower M400 smart glasses unit sales reduced product revenue. The net loss attributable to common shareholders narrowed to $7.1 million, or $0.09 per share, from $8.6 million, or $0.11 per share, mainly because general and administrative expense fell on a $1.7 million decline in non-cash stock-based compensation. Revenue and gross loss moved in opposite directions to the bottom line, and operating cash outflow widened to $5.6 million.
Total sales were $1.4 million versus $1.6 million a year earlier, down 12%, driven by lower product sales.
Net loss attributable to common shareholders was $7.1 million, or $0.09 per share, compared with $8.6 million, or $0.11 per share.
Gross loss widened to $0.4 million from $0.3 million; general and administrative expense fell to $2.1 million from $4.0 million.
Cash used in operating activities was $5.6 million versus $3.5 million in the prior-year period.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Vuzix Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →